Rhinovirus Induced Wheezing clinical trials

Explore recruiting rhinovirus induced wheezing clinical trials.

Recruiting rhinovirus induced wheezing studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Rhinovirus Induced Wheezing trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Oral Prednisolone for Acute Rhinovirus Induced Wheezing in Children Less Than 2 Years of Age: RhinoPOC RCT

Finland

Therapeutic use (Phase IV) EU CTIS Study details

Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced Wheezing - The INSTAR study

Finland, Sweden, Norway

Therapeutic use (Phase IV) EU CTIS Study details

Rhinovirus Induced Wheezing trials by city

Rhinovirus Induced Wheezing in Toronto Rhinovirus Induced Wheezing in Vancouver Rhinovirus Induced Wheezing in Montreal Rhinovirus Induced Wheezing in Calgary Rhinovirus Induced Wheezing in Edmonton Rhinovirus Induced Wheezing in Ottawa Rhinovirus Induced Wheezing in Winnipeg Rhinovirus Induced Wheezing in Quebec City Rhinovirus Induced Wheezing in Hamilton Rhinovirus Induced Wheezing in Kitchener Rhinovirus Induced Wheezing in London Rhinovirus Induced Wheezing in Halifax Rhinovirus Induced Wheezing in New York Rhinovirus Induced Wheezing in Los Angeles Rhinovirus Induced Wheezing in Chicago Rhinovirus Induced Wheezing in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease